Oxford Immunotec, Lophius Ink Licensing Deals for Development of T-cell-based Assays | GenomeWeb

NEW YORK (GenomeWeb News) – Oxford Immunotec and Lophius Biosciences said today that they have signed agreements providing each other access to certain intellectual property.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.